Aggressive Spinal Hemangioma

Launched by ASSIUT UNIVERSITY · May 27, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a specific type of tumor called aggressive spinal hemangiomas, which can cause pain and other serious problems in the spine. Researchers want to understand how these tumors show up in patients, how well different imaging tests (like X-rays and MRIs) can identify them, and how effective various treatments are. The main goal is to find the best ways to manage these tumors so that patients receive the best possible care.

To participate in this study, patients must have been diagnosed with aggressive spinal hemangiomas and experience symptoms such as pain, neurological issues, or instability in their spine. However, patients who have hemangiomas that were found by chance during tests for other conditions will not be included. The trial is not yet recruiting participants, but once it begins, those who are eligible can expect to be closely monitored and receive treatment tailored to their specific situation.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients diagnosed with aggressive spinal hemangiomas based on clinical symptoms and imaging findings.
• • Cases confirmed through diagnostic modalities such as X-ray, MRI, MSCT, or angiography.
• • Patients presenting with symptoms such as pain, neurological deficits, or spinal instability attributable to the hemangioma.
• Exclusion Criteria:
• • Patients with incidentally discovered spinal hemangiomas (asymptomatic cases found during evaluations for unrelated conditions).
• • Cases lacking sufficient diagnostic evidence to confirm aggressive spinal hemangioma.